0
0

Commission on America’s Medical Security Act

3/2/2022, 4:21 PM

Congressional Summary of S 3478

Commission on America's Medical Security Act

This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to report on the security of the U.S. medical product supply chain (i.e., supply of drugs and devices).

Among other things, the report shall

  • assess the dependence of the United States, including the private sector, states, and federal government, on critical drugs and devices sourced or manufactured outside of the United States; and
  • provide recommendations to address supply vulnerabilities or potential disruptions.

Current Status of Bill S 3478

Bill S 3478 is currently in the status of Bill Introduced since March 12, 2020. Bill S 3478 was introduced during Congress 116 and was introduced to the Senate on March 12, 2020.  Bill S 3478's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S1743) as of March 12, 2020

Bipartisan Support of Bill S 3478

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
11
Democrat Cosponsors
7
Republican Cosponsors
4
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 3478

Primary Policy Focus

Health

Potential Impact Areas

- Chemical and biological weapons
- Drug safety, medical device, and laboratory regulation
- Economic performance and conditions
- Emergency medical services and trauma care
- Emergency planning and evacuation
- Government studies and investigations
- Health care coverage and access
- Health technology, devices, supplies
- Infectious and parasitic diseases
- Manufacturing
- Terrorism

Alternate Title(s) of Bill S 3478

Commission on America’s Medical Security Act
Commission on America’s Medical Security Act
A bill to require a report to assess, evaluate, and address the dependence of the United States on critical drugs and devices sourced or manufactured outside of the United States.

Comments